Our CEO, Dr. Frank Mathias, and CFO, Dr. Lucinda (Lucy) Crabtree, will be presenting in person at the Jefferies Global Healthcare Conference in London on 18 November at 11:30 GMT / 6:30 ET. They will share how OXB is delivering on its strategy – driving growth, expanding capabilities, and strengthening our position as a leading partner in the development and manufacture of next-generation transformative therapies.
Register for the webcast here >